Showing results (371-380 of 464) with videos related to

Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Alterations affecting the p53 control pathway in bilharzial-related bladder cancerI Osman, H I Scher, Z F Zhang, et al.
Journal of the National Cancer Institute|September 7, 1994
Altered patterns of MDM2 and TP53 expression in human bladder cancerP Lianes, I Orlow, Z F Zhang, et al.
Cancer Detection and Prevention|January 1, 1995
Risk factors and p53 nuclear overexpression in early stage intestinal-type adenocarcinoma of the stomachZ F Zhang, M S Karpeh, G Y Lauwers, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetD O Hardy, H I Scher, T Bogenreider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcomeL Lacombe, G Dalbagni, Z F Zhang, et al.
Cancer Detection and Prevention|September 1, 1999
Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritisZ F Zhang, R C Kurtz, D S Klimstra, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 29, 2020
[Establishment of nutrition literacy core items for Chinese people]Y Q Zhang, Sumiya Aihemaitijiang, J Yang, et al.
Nutrition and Cancer|January 1, 1997
Adenocarcinomas of the esophagus and gastric cardia: the role of dietZ F Zhang, R C Kurtz, G P Yu, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|March 1, 1993
Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancerG Dalbagni, J C Presti, V E Reuter, et al.
Pageof 47